Cost-effectiveness analysis of cardiovascular disease prevention; a ranked list an aid to the rational distribution of resources;Analys av kostnadseffektiviteten vid prevention av hjärt-kärlsjukdom: Rankinglista ett hjälpmedel för att rätt fördela resurserna

Lakartidningen

Volumn 96, Issue 23, 1999, Pages 2858-2866

  Lindholm, Lars ^a,b   Hallgren, C G ^a   Boman, Kurt ^b   Markgren, Kenth ^a   Weinehall, Lars ^a,b   Ogren J E ^a  

^a Landstingshuset ^*  (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOCHOLESTEROLEMIC AGENT;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; DRUG COST; ECONOMICS; FEMALE; HEALTH CARE ORGANIZATION; HEALTH CARE PLANNING; HUMAN; MALE; MIDDLE AGED; PRACTICE GUIDELINE; PREVENTIVE HEALTH SERVICE; RISK FACTOR; STATISTICAL MODEL; SWEDEN;

ADULT; AGED; ANTICHOLESTEREMIC AGENTS; CARDIOVASCULAR DISEASES; COST-BENEFIT ANALYSIS; DRUG COSTS; FEMALE; GUIDELINES; HEALTH CARE RATIONING; HEALTH RESOURCES; HUMANS; MALE; MIDDLE AGED; MODELS, ECONOMIC; PREVENTIVE HEALTH SERVICES; RISK FACTORS; SWEDEN;

EID: 0033538183     PISSN: 00237205     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Vårdens svåra val - Slutbetänkande från prioriteringsutredningen. SOU 1995:5.
2. Drummond MF. Allocating resources. Int J Technol Assess Health Care 1990; 6: 77-92.
3. Weinstein MC. Principles of cost-effective resource allocation in health care organizations. Int J Technol Assess Health Care 1990; 6: 93-103.
4. Johannesson M, Weinstein MC. On the decision rules of cost-effectiveness analysis. Journal of Health Economics 1993; 12: 459-67.
5. Mason J, Drummond M. Reporting the guidelines for economic studies. Health Econ 1995; 4: 85-94.
6. Mason J, Drummond M, Torrance G. Some guidelines on the use of cost effectiveness league tables. BMJ 1993; 306: 570-2.
7. Birch S, Gafni A. Cost effectiveness/utility analyses. Do current decision rules lead us to where we want to be? Joournal of Health Economics 1992; 11: 279-96.
8. Birch S, Gafni A. Changing the problem to fit the solution: Johannesson and Weinstein's (mis) application of economics to real world problems. Journal of Health Economics 1993; 12: 469-76.
9. Gerard K, Mooney G. Qaly league tables: handle with care. Health Econ 1993; 2: 59-64.
10. Williams A. Cost-effectiveness analysis: is it ethical? J Med Ethics 1992; 18: 7-11.
11. Tengs TO, Adams ME, Pliskin JS, Safran DG, Siegel JE, Weinstein MC et al. Five hundred life-saving interventions and their cost-effectiveness. Risk Anal 1995; 15: 369-90.
12. Måttligt förhöjt blodtryck. SBU-rapport nr 121. Stockholm: SBU, 1994.
13. Kannel WB, Wolf PA, Garrison RJ, eds. The Framingham study. An epidemiological investigation of cardiovascular disease. Bethesda: National Institutes of Health, 1987. NHI Publication No 87-2284.
14. MONICA 10 år. En sammanfattande rapport över MONICA-projektet i norra Sverige. Umeå: Samhällsmedicin, landstingets kansli, 1997.
15. Hebert PR, Moser M, Mayer J, Hennekens CH. Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease. Arch Intern Med 1993; 153: 578-81.
16. Shepard J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995; 333: 1301-7.
17. Lindholm L, Rosén M, Weinehall L, Asplund K. Cost effectiveness and equity of a community based cardiovascular disease prevention programme in Norsjö, Sweden. J Epidemiol and Community Health 1996; 50: 190-5.
18. Perkins KA. Interactions among coronary heart disease risk factors. Ann Behav Med 1989; 11: 3-11.
19. Drummond MF, Stoddardt GL, Torrance GW. Methods of the health economic evaluation of health care programmes. Oxford: Oxford University Press, 1987.
20. Alt förebygga sjukdom i hjärta och kärl genom befolkningsinriktade program - en systematisk litteraturöversikt. SBU-rapport nr 134. Stockholm: SBU, 1997.